echoloc

EMS Tech Stack

Brazil's leading pharmaceutical manufacturer with generics and biotech innovation

Pharmaceutical Manufacturing Hortolandia, SP 1,001–5,000 employees Founded 1964 Privately Held

EMS is the dominant player in Brazil's pharmaceutical market, operating four manufacturing facilities across the country and maintaining a tech stack anchored in enterprise pharma tools (Veeva, IQVIA, SAP, LIMS). The hiring acceleration—10 roles in the last 30 days—skews heavily toward sales (five positions) and research (two), reflecting a scaling strategy around market penetration and portfolio innovation rather than platform infrastructure.

Tech Stack 13 technologies

Core StackPower BI SAP Veeva Outlook Teams Excel Word PowerPoint IQVIA HPLC GCP ICP-MS LIMS

What EMS Is Building

Challenges

  • Ensuring bidding compliance
  • Reducing delinquency
  • Risk and delivery management
  • Technical regulatory viability
  • Bidding process compliance
  • Public channel sales growth
  • Optimizing e-commerce performance
  • Conformidade regulatória
  • Manter documentação atualizada
  • Análises de impacto em processos

Active Projects

  • Analytical studies
  • Clinical studies
  • Portfolio innovation
  • Licitation processes
  • Strategic portfolio penetration
  • Market monitoring action plans
  • Bid and rfp process optimization
  • Digital campaign coordination
  • Desenvolver indicadores de qualidade
  • Conduzir análises de impacto em processos

Hiring Activity

Accelerating10 roles · 10 in 30d

Department

Sales
5
Research
2
Engineering
1
Manufacturing
1
Marketing
1
Quality
1

Seniority

Junior
6
Mid
3
Manager
2
Company intelligence

Find more companies like EMS by tech stack, pain points and active projects

Get started free

About EMS

EMS manufactures and distributes pharmaceuticals across prescription, generic, OTC, and hospital segments in Brazil, operating four production facilities in Hortolandia, Manaus, Brasilia, and Jaguariuna. The company combines domestic market leadership in generics with an international R&D footprint: a research center in Italy (MonteResearch) and U.S.-based biotech operations (Bionovis for biotechnology; Brace Pharma for disruptive innovation; Vero Biotech). The product portfolio spans nearly all medical specialties, with significant strength in high-complexity generics and emerging biotech medicines. The organization maintains regulatory compliance, supply-chain efficiency, and market access as core operational priorities.

HeadquartersHortolandia, SP
Company Size1,001–5,000 employees
Founded1964
Hiring MarketsBrazil

Frequently Asked Questions

What is EMS's market position in Brazil?

EMS holds the #1 position in the Brazilian pharmaceutical market (19 consecutive years) and leads the generics segment since 2013. The company is also among the largest by prescriber preference.

What technology does EMS use for pharmaceutical operations?

EMS operates Veeva (pharma-specific CRM/compliance), IQVIA (market intelligence), SAP (enterprise resource planning), LIMS (laboratory information management), and Power BI (analytics), plus standard Microsoft Office and GCP.

Similar Companies in Pharmaceutical Manufacturing

Other companies in the same industry, closest in size